innoVitroThis months article is an intersting review that summarizes the current understanding of potential cardiovascular toxicities of CD19-specific Car T cell therapies. CD19-specific chimeric antigen receptor (CAR) T cell therapies have shown remarkable early success in highly refractory and relapsing hematological malignancies. However, most significant side effects of the therapy are cytokine release syndrome (CRS)…Continue readinginnoVation Series – Research Article of the Month – April 2021
Our partner Nanion Technologies will present this upcoming Cardiac Safety Symposium with keynote speakers of the saftey pharmacological field including our Scientific Communications Manager Bettina Lickiss, who will present cardiac contractility assessment data with integrated optical and mechanical stimulation of human iPSC-derived cardiomyocytes. Register here Check out the FLEXcyte technology hereContinue readingCardiac Safety Symposium May 19 – 20, 2021
This month’s innovation series research article was published from our colleagues at the University of Cologne last week. Find out how you can optimize cardiac differentiation out of human induced pluripotent stem cells. This biomimetic approach is based on poly(dimethylsiloxane) (PDMS) substrates with similar stiffness to the native heart and a well-defined surface chemistry obtained…Continue readinginnoVation Series – Research Article of the Month – March 2021
Come and meet us virtually at this years Society of Toxicology (SOT) Conference!Continue readingMarch 12 – 26, 2021
Connect with us at the ELRIG Research and Innovation Conference held virtually!Continue readingFebruary 23-24, 2021
Join us at FUJIFILM Cellular Dynamics iFORUM Virtual User Group Meeting.Continue readingJanuary 27 – 28, 2021
Click on the following link to download the article “Integration of mechanical conditioning into a high throughput contractility assay for cardiac safety assessment” published by innoVitro GmbH and Nanion Technologies! https://authors.elsevier.com/a/1b-La3mJWhOVY7Continue readingGet your free download of our most recent article published in the “Journal of Pharmacological and Toxicological Methods” here!
We are happy to announce our membership of the Botanical Safety Consortium (BSC)! The BSC is a forum for scientists from consumer health groups, academia, industry, non-profits, and government to generate a scientifically based integration of existing safety data and toxicology tools to evaluate botanical safety. BSC Members will work collaboratively on a variety of…Continue readinginnoVitro is a founding member of the Botanical Safety Consortium
The winners of the 2020 FLEXcyte Grant were finally announced!Continue readingFLEXcyte Grant Winners 2020
innoVitro supports doctors and nurses in the fight against Covid-19!Continue readingWe support our local heroes
